Range
- - -
Vol / Avg.
-/772.8K
Div / Yield
-
52 Wk
25.49 - 65.67
Mkt Cap
5.2B
Payout Ratio
-
Open
-
P/E
-
EPS
-2.32
Shares
80.5M
Outstanding
80.5M
Total Float
53.8M
load more
Sector: Health Care.Industry: Biotechnology
Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3 the central protein in the complement cascade.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-07-30
REV
Q1 2021Est.ActualSurprise
EPS-1.620-2.320 -0.7000
REV2.270M0-2.270M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
APLSApellis Pharmaceuticals0%5.2B

Apellis Pharmaceuticals Frequently Asked Questions

Q

How do I buy Apellis Pharmaceuticals (APLS) stock?

A

You can purchase shares of Apellis Pharmaceuticals (NASDAQ: APLS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Apellis Pharmaceuticals's (APLS) competitors?

Q

What is the target price for Apellis Pharmaceuticals (APLS) stock?

A

The latest price target for Apellis Pharmaceuticals (NASDAQ: APLS) was reported by UBS on May 21, 2021. The analyst firm set a price target for 82.00 expecting APLS to rise to within 12 months (a possible 26.47% upside). 12 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Apellis Pharmaceuticals (APLS)?

A

The stock price for Apellis Pharmaceuticals (NASDAQ: APLS) is $64.84 last updated Wed Jun 23 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Apellis Pharmaceuticals (APLS) pay a dividend?

A

There are no upcoming dividends for Apellis Pharmaceuticals.

Q

When is Apellis Pharmaceuticals (NASDAQ:APLS) reporting earnings?

A
Apellis Pharmaceuticals’s Q2 earnings are confirmed for after-market on July 30, 2021.
Q

Is Apellis Pharmaceuticals (APLS) going to split?

A

There is no upcoming split for Apellis Pharmaceuticals.

Q

What sector and industry does Apellis Pharmaceuticals (APLS) operate in?

A

Apellis Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.